
CellaVision AB
STO:CEVI

CellaVision AB
Total Assets
CellaVision AB
Total Assets Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Company | Total Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
---|---|---|---|---|---|---|
![]() |
CellaVision AB
STO:CEVI
|
Total Assets
kr1B
|
CAGR 3-Years
7%
|
CAGR 5-Years
10%
|
CAGR 10-Years
17%
|
|
![]() |
Elekta AB (publ)
STO:EKTA B
|
Total Assets
kr31.4B
|
CAGR 3-Years
8%
|
CAGR 5-Years
5%
|
CAGR 10-Years
N/A
|
|
S
|
Surgical Science Sweden AB
STO:SUS
|
Total Assets
kr5.5B
|
CAGR 3-Years
11%
|
CAGR 5-Years
64%
|
CAGR 10-Years
N/A
|
|
![]() |
Getinge AB
STO:GETI B
|
Total Assets
kr63.9B
|
CAGR 3-Years
13%
|
CAGR 5-Years
7%
|
CAGR 10-Years
N/A
|
|
![]() |
Arjo AB (publ)
STO:ARJO B
|
Total Assets
kr16.3B
|
CAGR 3-Years
4%
|
CAGR 5-Years
2%
|
CAGR 10-Years
N/A
|
|
S
|
Stille AB
STO:STIL
|
Total Assets
kr927.7m
|
CAGR 3-Years
75%
|
CAGR 5-Years
44%
|
CAGR 10-Years
N/A
|
CellaVision AB
Glance View
CellaVision AB engages in the provision of automated microscopy systems in the field of hematology. The company is headquartered in Lund, Skane and currently employs 200 full-time employees. The company went IPO on 2007-05-28. The firm develops and sells digital solutions for medical microscopy, as well as products enabling blood cell analysis and morphology diagnosis. CellaVision AB’s product portfolio consists of analyzers for automated medical microscopy analysis and software applications designed for remote access, competency testing and education. The analyzers include such brands as CellaVision DM96 and CellaVision DM1200, whereas the software applications are divided into CellaVision Body Fluid Application, CellaVision Remote Review Software and CellaVision Competency Software, among others. The firm operates four subsidiaries, based in Sweden, Canada, the United States and Japan. In June 2014, CellaVision AB acquired technology platform from Clear Lake Medical Foundation.

See Also
What is CellaVision AB's Total Assets?
Total Assets
1B
SEK
Based on the financial report for Dec 31, 2024, CellaVision AB's Total Assets amounts to 1B SEK.
What is CellaVision AB's Total Assets growth rate?
Total Assets CAGR 10Y
17%
Over the last year, the Total Assets growth was 9%. The average annual Total Assets growth rates for CellaVision AB have been 7% over the past three years , 10% over the past five years , and 17% over the past ten years .